Free Trial

Premier (PINC) Competitors

$18.92
+0.19 (+1.01%)
(As of 05/31/2024 ET)

PINC vs. MANT, TMX, RCM, EVH, FC, IT, BIO.B, ASND, LEGN, and BRBR

Should you be buying Premier stock or one of its competitors? The main competitors of Premier include ManTech International (MANT), Terminix Global (TMX), R1 RCM (RCM), Evolent Health (EVH), Franklin Covey (FC), Gartner (IT), Bio-Rad Laboratories (BIO.B), Ascendis Pharma A/S (ASND), Legend Biotech (LEGN), and BellRing Brands (BRBR).

Premier vs.

ManTech International (NASDAQ:MANT) and Premier (NASDAQ:PINC) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, community ranking, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

ManTech International pays an annual dividend of $1.64 per share and has a dividend yield of 1.7%. Premier pays an annual dividend of $0.84 per share and has a dividend yield of 4.4%. ManTech International pays out 55.2% of its earnings in the form of a dividend. Premier pays out 131.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Premier has raised its dividend for 3 consecutive years. Premier is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Premier has lower revenue, but higher earnings than ManTech International. Premier is trading at a lower price-to-earnings ratio than ManTech International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ManTech International$2.55B1.54$137.02M$2.9732.32
Premier$1.34B1.48$175.03M$0.6429.56

Premier has a consensus target price of $23.50, suggesting a potential upside of 24.21%. Given ManTech International's higher probable upside, analysts clearly believe Premier is more favorable than ManTech International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ManTech International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Premier
1 Sell rating(s)
10 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

94.5% of ManTech International shares are held by institutional investors. Comparatively, 74.4% of Premier shares are held by institutional investors. 1.4% of ManTech International shares are held by company insiders. Comparatively, 0.9% of Premier shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

ManTech International has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, Premier has a beta of 0.39, suggesting that its stock price is 61% less volatile than the S&P 500.

In the previous week, Premier had 16 more articles in the media than ManTech International. MarketBeat recorded 16 mentions for Premier and 0 mentions for ManTech International. ManTech International's average media sentiment score of 0.69 beat Premier's score of 0.00 indicating that Premier is being referred to more favorably in the news media.

Company Overall Sentiment
ManTech International Neutral
Premier Positive

Premier received 267 more outperform votes than ManTech International when rated by MarketBeat users. Likewise, 69.00% of users gave Premier an outperform vote while only 50.15% of users gave ManTech International an outperform vote.

CompanyUnderperformOutperform
ManTech InternationalOutperform Votes
345
50.15%
Underperform Votes
343
49.85%
PremierOutperform Votes
612
69.00%
Underperform Votes
275
31.00%

Premier has a net margin of 6.01% compared to Premier's net margin of 4.67%. ManTech International's return on equity of 11.71% beat Premier's return on equity.

Company Net Margins Return on Equity Return on Assets
ManTech International4.67% 8.00% 5.28%
Premier 6.01%11.71%7.31%

Summary

Premier beats ManTech International on 12 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PINC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PINC vs. The Competition

MetricPremierManagement services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.98B$5.37B$5.11B$7.97B
Dividend Yield4.44%3.54%2.75%4.00%
P/E Ratio29.5616.90120.3615.18
Price / Sales1.4869.052,428.4593.40
Price / Cash5.3915.2035.0431.51
Price / Book1.039.955.524.59
Net Income$175.03M$225.26M$105.88M$213.90M
7 Day Performance-0.37%-1.92%1.13%0.87%
1 Month Performance-10.16%-4.51%1.42%3.60%
1 Year Performance-24.50%-11.11%4.04%7.91%

Premier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MANT
ManTech International
0 of 5 stars
$95.98
flat
N/A+0.0%$3.93B$2.55B32.329,800Analyst Forecast
TMX
Terminix Global
0 of 5 stars
$37.87
flat
N/AN/A$4.61B$2.05B71.4511,700
RCM
R1 RCM
4.7459 of 5 stars
$12.99
+0.9%
$16.31
+25.5%
-20.9%$5.47B$2.25B-162.3830,000Positive News
EVH
Evolent Health
2.0237 of 5 stars
$21.53
+0.3%
$42.00
+95.1%
-27.3%$2.50B$1.96B-17.224,700News Coverage
FC
Franklin Covey
3.6067 of 5 stars
$36.59
+0.1%
$66.33
+81.3%
+0.2%$485.40M$279.13M29.751,160Analyst Forecast
Short Interest ↓
IT
Gartner
4.0367 of 5 stars
$419.00
-2.0%
$474.50
+13.2%
+22.4%$32.53B$5.90B41.6920,237Analyst Downgrade
BIO.B
Bio-Rad Laboratories
0 of 5 stars
$279.91
flat
N/A-25.1%$7.98B$2.67B-27.027,900Positive News
ASND
Ascendis Pharma A/S
3.2283 of 5 stars
$134.79
+1.7%
$176.88
+31.2%
+55.3%$7.85B$288.08M-14.03879Analyst Forecast
Short Interest ↓
LEGN
Legend Biotech
2.5841 of 5 stars
$42.78
+1.7%
$81.10
+89.6%
-37.6%$7.80B$285.14M-32.911,800
BRBR
BellRing Brands
2.8097 of 5 stars
$58.05
-0.5%
$62.23
+7.2%
+58.7%$7.57B$1.67B40.31420Analyst Revision

Related Companies and Tools

This page (NASDAQ:PINC) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners